Evaluation of annotation using the Genome Guide System for Comprehensive Genomic Profiling with Tissue and Blood Samples in Patients with Solid Tumors.

Evaluation of annotation using the Genome Guide System for Comprehensive Genomic Profiling with Tissue and Blood Samples in Patients with Solid Tumors. - Evaluation of annotation using the Genome Guide System for Comprehensive Genomic Profiling with Tissue and Blood Samples in Patients with Solid Tumors.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047265

Enrollment

Registered

2022-03-23

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Solid cancer cases (2) Patients who underwent cancer gene panel test using tissue samples at St. Marianna University Hospital (3) Cases in which gene panel testing can be performed using surplus specimens from routine blood tests.

Exclusion criteria

Exclusion criteria: Cases in which the principal investigator determines that participation in this study is inappropriate

Design outcomes

Primary

Measure	Time frame
Annotation success rate (tissue specimen data vs. blood specimen data)	—

Countries

Japan

Contacts

Public ContactYu Sunakawa

St. Marianna University School of Medicine Department of Clinical Oncology

y.sunakawa@marianna-u.ac.jp0449778111

Outcome results